Viemed Healthcare (VMD) Cost of Revenue (2018 - 2026)

Viemed Healthcare (VMD) has reported Cost of Revenue for 9 consecutive years, with $33.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 25.54% year-over-year to $33.0 million; the trailing twelve-month figure through Jun 2026 stood at $128.3 million (up 27.82% YoY), and the FY2025 full-year result was $114.8 million, up 26.1% from the prior year.
• Cost of Revenue climbed to $33.0 million in Q2 2026 per VMD's latest filing, from $32.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $33.0 million in Q2 2026 and bottomed at $12.5 million in Q1 2022.
• Historically, Cost of Revenue has averaged $22.0 million across 5 years, with a median of $21.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue grew 17.22% in 2022, then jumped 33.69% in 2024.
• Over 5 years, Cost of Revenue stood at $14.6 million in 2022, then grew by 27.48% to $18.6 million in 2023, then soared by 31.83% to $24.6 million in 2024, then jumped by 30.63% to $32.1 million in 2025, then advanced by 3.03% to $33.0 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $33.0 million, $32.6 million, and $32.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.